EGC is pleased to sponsor the Redefining Early Stage Investments (RESI) Conference at the JP Morgan Conference in San Francisco on January 9, 2024. We are excited to meet with current and future clients to implement strategies for accessing government funding to advance cutting-edge healthcare technologies in 2024!
Accelerating development of innovative technologies
EGC’s extraordinary team of scientists and accountants are ready to secure and manage non-dilutive funding to support your scientific innovations. Contact us to learn more.
Related Posts
July 19, 2024
EGC Profiled in WRAL TechWire
Article highlights EGC’s success in supporting the NIH’s Applicant Assistance Program and winning the SBA’s Growth Accelerator Fund Competition…
July 18, 2024
July 2024 Newsletter
Client highlight: nCap Technologies is redefining what is possible with its recent Phase I Small Business Innovation Research (SBIR) award from the…
July 17, 2024
EGC & the NIH Significantly Expand Participation in SBIR Grants
Nature Biotechnology article showcases the first programmatic intervention proven to broaden representation among SBIR grant awardees in four…
July 9, 2024
EGC and Brooks Pierce co-hosts new webinar series
Exclusive opportunity for EGC clients: Please join us for a four-part grant accounting and legal compliance webinar series that runs between July and…